IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and ...

IDEXX Laboratories' oncology panel and share buybacks boost outlook. Read why IDXX stock is upgraded to buy with growth ...

Avantax Advisory Services Inc. decreased its holdings in IDEXX Laboratories, Inc. (NASDAQ:IDXX – Free Report) by 36.9% in the ...

We came across a bullish thesis on IDEXX Laboratories, Inc. (IDXX) on Substack by Hidden Market Gems. In this article, we ...

With a market cap of $33 billion, IDEXX Laboratories, Inc. (IDXX) develops, manufactures, and distributes products for the ...

Moreover, pet owners have demonstrated greater willingness to spend more on their animals, having more than tripled spending on pet products and services since 1994. Idexx Labs reported quarterly ...

The Companion Animal Group diagnostics segment registered a 6% growth, driving the overall positive earnings performance. Idexx Laboratories exceeded earnings expectations for Q4 2024, buoyed by ...

IDEXX Laboratories, Inc. engages in the development, manufacture, and distribution of products and services for the animal veterinary, livestock and poultry, dairy, and water testing markets.

IDEXX Laboratories, Inc. IDXX is well-poised to grow in the upcoming quarters due to the performance of its CAG (Companion Animal Group) Diagnostics business. The consistent growth in international ...

Idexx Laboratories, a global leader in veterinary ... Its operations are primarily anchored by the Companion Animal Group (CAG), which caters to the increasing demand for advanced pet care ...

IDEXX Laboratories, Inc.’s IDXX fourth-quarter performance was driven by the consistent strong performance of the Companion Animal Group (“CAG”) segment. Solid performance in the ...